R
Robert H. Bartlett
Researcher at University of Michigan
Publications - 569
Citations - 28295
Robert H. Bartlett is an academic researcher from University of Michigan. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Extracorporeal. The author has an hindex of 81, co-authored 550 publications receiving 25619 citations. Previous affiliations of Robert H. Bartlett include University of California, Irvine & NewYork–Presbyterian Hospital.
Papers
More filters
Journal Article
Prolonged extracorporeal circulation.
Journal ArticleDOI
Prolonged (24-hour) Normothermic ex vivo Heart Perfusion Facilitated by Perfusate Hemofiltration
Matthew D. Johnson,Brian P. Fallon,Mark W. Langley,Adrianna M Kayden,Hannah Shenton,B Schneider,Mark J. Hoenerhoff,Jonathan W. Haft,Daniel H Drake,Gabe E. Owens,Alvaro Rojas-Pena,Robert H. Bartlett +11 more
TL;DR: Using the authors' circuit, NEVHP for 24 hours is possible with HFn and allows for preservation of myocardial function, improved tissue viability, decreased tissue edema, and less myocardIAL injury.
Journal ArticleDOI
Ethics of Proxy Consent for Research Involving Patients With Adult Respiratory Distress Syndrome-Reply
TL;DR: There is not a substantial difference between obtaining informed consent from the patient's representative for standard care or for an innovative treatment, and in all cases, the tenets of informed consent must be explained thoroughly in an understandable language to a patient advocate who can represent the interest of the currently incompetent patient.
Journal ArticleDOI
BIO7: PAL-LR: a Reduced Resistance, Concentric-Gated Artificial Membrane Lung for Pediatric End-Stage Lung Failure
Lauren Wich,Leah M. Gudex,Tyler Dann,Hannah J. Matich,Alex J. Thompson,Matthew D. Johnson,Robert H. Bartlett,Alvaro Rojas Pena,Joseph A. Potkay,Ronald B. Hirschl +9 more
TL;DR: The Low Resistance Pediatric MLung (PAL-LR) as discussed by the authors was developed to serve as a pumpless (pulmonary artery to left atrium) bridge-to-transplant device for small children with end stage lung failure.
cardiac surgery Outcome of pediatric patients treated with extracorporeal life support after
Robert H. Bartlett,Thomas J. Kulik,Nikoleta S. Kolovos,Susan L. Bratton,Frank W. Moler,Edward L. Bove +5 more
TL;DR: The outcome of pediatric patients treated with extracorporeal life support after cardiac surgery outcome is compared with that of children treated with conventional treatment.